offline
Walgreens stock dives after Goldman downgrade on concerns about core business
Goldman’s new stock price target is about 14% below Friday’s trading level
Walgreens Boots Alliance Inc. shares fell 4% Friday, after Goldman Sachs downgraded the stock to sell from neutral, citing concerns about a deteriorating performance at its core retail pharmacy business as reimbursement rates fall and front-end sales decline.
“Challenges in its retail pharmacy business have intensified, forcing the company to search for other avenues of growth,” analysts led by Robert Jones wrote in a note. Goldman lowered its 12-month price target on the stock to $68 from $73, or about 14% below Friday’s trading level.
...
https://www.marketwatch.com/story/walgre...2018-12-14
Goldman’s new stock price target is about 14% below Friday’s trading level
Walgreens Boots Alliance Inc. shares fell 4% Friday, after Goldman Sachs downgraded the stock to sell from neutral, citing concerns about a deteriorating performance at its core retail pharmacy business as reimbursement rates fall and front-end sales decline.
“Challenges in its retail pharmacy business have intensified, forcing the company to search for other avenues of growth,” analysts led by Robert Jones wrote in a note. Goldman lowered its 12-month price target on the stock to $68 from $73, or about 14% below Friday’s trading level.
...
https://www.marketwatch.com/story/walgre...2018-12-14
__________________
